Alan Barragan Filigrana

I completed my Bachelor’s degree in Biotechnology at Anáhuac University, where my thesis focused on DNA methylation patterns in fibroblast-derived induced pluripotent stem cells (iPSCs). During the final year of my degree, I worked as a Laboratory Assistant at World Stem Cells Clinic (WSCC), where I participated in the production of mesenchymal cell therapies for patients with Autism Spectrum Disorder (ASD) and in the development of RNA vaccines for cancer therapy. In March 2025, I joined the Farrow Group as a visiting student, working on the optimization of an oligodendrocyte differentiation protocol to establish an in vitro model of Alzheimer’s disease, collaborating with Fernandes Group. After completing this internship, I joined to the Fernandes Group as a Research Assistant, collaborating with the Farrow Group. My current research focuses on investigating the molecular mechanisms underlying oligodendrocyte dysfunction in human in vitro models of Alzheimer’s disease, aiming to advance our understanding of neurodegenerative processes through iPSC-based systems.